Drugs and Clinic Practice

The clinical application value of mitoxantrone hydrochloride injection and carbon nanoparticles suspension injection in endoscopic radical thyroidectomy for thyroid cancer

  • Jinlian WANG ,
  • Shengchang LIANG ,
  • Yibin GUO ,
  • Qi ZHANG ,
  • Kunpeng QU ,
  • Xiaopeng HAN
Expand
  • The First Clinical Medical College,Gansu University of Chinese Medicine,Lanzhou 730000,Gansu,China

Received date: 2024-12-28

  Online published: 2025-07-02

Abstract

Objective To explore the significance of mitoxantrone hydrochloride injection and carbon nanoparticles suspension injection in endoscopic radical thyroid cancer surgery. Methods A retrospective analysis was carried out on patients who underwent endoscopic radical surgery for unilateral thyroid cancer at the Department of General Surgery, Gansu Provincial Central Hospital, from December 2022 to February 2024. The patients were classified into two groups according to the intraoperative tracer employed: the mitoxantrone group and the nanocarbon group. After a 6-month postoperative follow-up, the baseline data of the two patient groups were compared. The intraoperative visualization of lymph nodes and parathyroid glands in both groups was observed. Additionally, the hospitalization costs and the incidence of postoperative complications were compared between the two groups. Results In this study, 110 cases were included in the Mitoxantrone group and 126 cases in the nanocarbon group. The staining time of the central lymph nodes was significantly shorter in the nanocarbon group compared to the mitoxantrone group (P < 0.05). The blue staining rate of MHI reached 97.5%, while the black staining rate of CNSI was 98.3%. The difference between them was not statistically significant (P > 0.05). Regarding the number of central lymph nodes dissected, it was 9.34 ± 0.22 in the Mitoxantrone group and 9.88 ± 0.24 in the nanocarbon group, with no statistically significant difference (P > 0.05). Similarly, the parathyroid misdissection rates were 1.8% and 0.8% in the two groups respectively, and no significant statistical difference was observed (P > 0.05). Postoperative blood calcium and PTH levels measured at 1 day, 1 month, and 6 months did not show any statistically significant differences between the two groups (P > 0.05). The incidence of transient hypoparathyroidism and hypocalcemia was comparable in both groups (P > 0.05), and no patients developed permanent hypoparathyroidism or permanent hoarseness. None of the patients in one Mitoxantrone group experienced postoperative hemorrhage, coeliac leakage, or skin staining. In contrast, in the nanocarbon group, there was one case of postoperative hemorrhage and one case of coeliac leakage, and two case of skin staining. Conclusions In laparoscopic unilateral thyroid cancer radical surgery, when it comes to lymph node tracing and parathyroid gland protection, no significant disparities were detected between MHI and CNSI. Nevertheless, CNSI exhibits a shorter staining time for central lymph nodes. In contrast, MHI is more manageable, features a faster metabolic rate, and has been demonstrated to be more cost-effective.

Cite this article

Jinlian WANG , Shengchang LIANG , Yibin GUO , Qi ZHANG , Kunpeng QU , Xiaopeng HAN . The clinical application value of mitoxantrone hydrochloride injection and carbon nanoparticles suspension injection in endoscopic radical thyroidectomy for thyroid cancer[J]. The Journal of Practical Medicine, 2025 , 41(12) : 1885 -1891 . DOI: 10.3969/j.issn.1006-5725.2025.12.017

References

1 GRIMM D. Recent Advances in Thyroid Cancer Research [J]. Int J Mol Sci, 2022, 23(9):4631. doi:10.3390/ijms23094631
2 余江涛, 王世杰, 张高飞,等. 血清甲状腺球蛋白、促甲状腺激素联合检测对行甲状腺全切术后未接受清甲治疗的分化型甲状腺癌患者复发的预测价值 [J]. 实用医学杂志, 2023, 39(9): 1159-1163.
3 ZHOU T, WANG X, ZHANG J, et al. Global burden of thyroid cancer from 1990 to 2021: A systematic analysis from the Global Burden of Disease Study 2021 [J]. J Hematol Oncol, 2024, 17(1): 74. doi:10.1186/s13045-024-01593-y
4 PIZZATO M, LI M, VIGNAT J, et al. The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020 [J]. Lancet Diabetes Endocrinol, 2022, 10(4): 264-272. doi:10.1016/s2213-8587(22)00035-3
5 赵铎. 磁共振成像在甲状腺癌淋巴结转移诊断中的应用 [J]. 实用医学影像杂志, 2021, 22(3): 314-316.
6 SCHLUMBERGER M, LEBOULLEUX S. Current practice in patients with differentiated thyroid cancer [J]. Nat Rev Endocrinol, 2021, 17(3): 176-188. doi:10.1038/s41574-020-00448-z
7 SCHELLER B, CULIé D, POISSONNET G, et al. Recent Advances in the Surgical Management of Thyroid Cancer [J]. Curr Oncol, 2023, 30(5): 4787-4804. doi:10.3390/curroncol30050361
8 ZHANG R J, CHEN Y L, DENG X, et al. Carbon Nanoparticles for Thyroidectomy and Central Lymph Node Dissection for Thyroid Cancer [J]. Am Surg, 2023, 89(6): 2227-2236. doi:10.1177/00031348221086780
9 LO C Y. Lymph Node Dissection for Papillary Thyroid Carcinoma [J]. Methods Mol Biol, 2022, 2534: 57-78. doi:10.1007/978-1-0716-2505-7_5
10 GAO H, LIU X, YU X, et al. Application of Nano-Carbon Tracing Technology in Thyroid Cancer and Its Relationship with Cytotoxic T Lymphocyte Antigen 4 Gene Polymorphism [J]. J Nanosci Nanotechnol, 2021, 21(2): 949-954. doi:10.1166/jnn.2021.18635
11 孙振华,赵志泓,蒋华平.甲状腺微小乳头状癌rⅥb区淋巴结转移因素分析及术中纳米碳应用价值研究[J].临床耳鼻咽喉头颈外科杂志,2020,34(4):355-359.
12 JIAO D, YANG B, CHEN J, et al. Efficacy and Safety of Mitoxantrone Hydrochloride Injection for Tracing Axillary Sentinel Nodes in Breast Cancer: A Self-Controlled Clinical Trial [J]. Front Oncol, 2022, 12: 914057. doi:10.3389/fonc.2022.914057
13 CHEN S, HOU X, HUA S, et al. Mitoxantrone hydrochloride injection for tracing helps to decrease parathyroid gland resection and increase lymph node yield in thyroid cancer surgery: A randomized clinical trial [J]. Am J Cancer Res, 2022, 12(9): 4439-4447.
14 陈少博, 刘玮楠, 张圣洁, 等. 示踪用盐酸米托蒽醌注射液用于甲状腺癌前哨淋巴结示踪的临床疗效、安全性及药代动力学Ⅰ期试验[J]. 协和医学杂志, 2021, 12(5): 729-735.
15 中国医疗保健国际交流促进会甲状腺疾病防治分会, 中华预防医学会甲状腺疾病防治专业委员会, 中国人体健康科技促进会甲状腺肿瘤专业委员会. 甲状腺癌手术中淋巴结示踪技术规范应用专家共识[J]. 中华医学杂志, 2022, 102(48): 3836-3841.
16 KOIMTZIS G D, STEFANOPOULOS L, GIANNOULIS K, et al. What are the real rates of temporary hypoparathyroidism following thyroidectomy? It is a matter of definition: A systematic review [J]. Endocrine, 2021, 73(1): 1-7. doi:10.1007/s12020-021-02663-8
17 WANG R, MO S, LIU Q, et al. The safety and effectiveness of carbon nanoparticles suspension in tracking lymph node metastases of colorectal cancer: A prospective randomized controlled trial [J]. Jpn J Clin Oncol, 2020, 50(5): 535-542. doi:10.1093/jjco/hyaa011
18 ZHU L B, ZHU F, LI P F, et al. Infiltration of nanocarbon suspension into the tracheal cavity during surgical treatment of papillary thyroid carcinoma: A case report [J]. J Int Med Res, 2020, 48(4): 300060520919251. doi:10.1177/0300060520919251
19 朱精强. 甲状腺手术中甲状旁腺保护专家共识 [J]. 中国实用外科杂志, 2015, 35(7): 731-736.
20 郎罡, 李馨颐, 王淑君. 新型淋巴示踪剂—示踪用盐酸米托蒽醌注射液 [J]. 中国临床药理学杂志, 2024, 40(4): 615-618.
21 YANG B, ZHENG S, HUANG X, et al. A single-center, self-controlled, phase I clinical trial of mitoxantrone hydrochloride injection for lymph tracing for sentinel lymph node identification of breast cancer [J]. Gland Surg, 2021, 10(3): 992-1001. doi:10.21037/gs-20-694
22 CHEN Z, ZHONG Z, CHEN G, et al. Application of Carbon Nanoparticles in Neck Dissection of Clinically Node-Negative Papillary Thyroid Carcinoma [J]. Biomed Res Int, 2021, 2021: 6693585. doi:10.1155/2021/6693585
23 RAO S S, RAO H, MOINUDDIN Z, et al. Preservation of parathyroid glands during thyroid and neck surgery [J]. Front Endocrinol (Lausanne), 2023, 14: 1173950. doi:10.3389/fendo.2023.1173950
24 LU D, PAN B, TANG E, et al. Intraoperative strategies in identification and functional protection of parathyroid glands for patients with thyroidectomy: A systematic review and network meta-analysis [J]. Int J Surg, 2024, 110(3): 1723-1734. doi:10.1097/js9.0000000000000991
Outlines

/